In one more baby step that could be in the direction of returning to a new normal, drug manufacturer Pfizer announced Wednesday morning the promising results of its COVID vaccine on young teenagers.
The results of the study showed that in a Phase 3 trial among 2,260 12- to 15-year-olds in the United States, 18 in the placebo group showed symptoms of COVID-19; and none of the vaccinated group showed any signs of the virus.
On the surface this seems like more good news that will lead to schools fully reopening in the fall, but there still has to be some caution.
COVID might be here to stay and humans have to remain vigilant against its spread.
Continue Reading on savannahnow